Krithika Rajagopalan

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 17

Top Topics

Diffuse Large B Cell Lymphoma

Cognitive Impairment

Endoplasmic Reticulum

Top Venues

Journal of comparative effectiveness research

Drugs - real world outcomes

ClinicoEconomics and outcomes research : CEOR

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics. Journal of comparative effectiveness research 13 (7) (2024)
Krithika Rajagopalan, Nazia Rashid, Vinod Yakkala, Dilesh Doshi
Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson's Disease Psychosis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes 11 (3) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes 11 (3) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Falls and Fractures among Nursing Home Residents Treated with Pimavanserin versus Other Atypical Antipsychotics: Analysis of Medicare Beneficiaries with Parkinson's Disease Psychosis. Drugs - real world outcomes 11 (3) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics. Journal of comparative effectiveness research 13 (7) (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics. Journal of comparative effectiveness research (2024)
Krithika Rajagopalan, Nazia Rashid, Daksha Gopal, Dilesh Doshi
Healthcare resource utilization among nursing home residents with Parkinson's disease psychosis: an analysis of Medicare beneficiaries treated with pimavanserin or other-atypical antipsychotics. Journal of comparative effectiveness research 13 (7) (2024)
Krithika Rajagopalan, Nazia Rashid, Vinod Yakkala, Dilesh Doshi
Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson's Disease Psychosis. ClinicoEconomics and outcomes research : CEOR 16 (2024)
Krithika Rajagopalan, Nazia Rashid, Dilesh Doshi
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of comparative effectiveness research 13 (1) (2023)
Krithika Rajagopalan, Nazia Rashid, Dilesh Doshi
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of comparative effectiveness research 13 (1) (2023)
Krithika Rajagopalan, Nazia Rashid, Dilesh Doshi
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of comparative effectiveness research 13 (1) (2023)
Krithika Rajagopalan, Nazia Rashid, Dilesh Doshi
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of comparative effectiveness research (2023)
Krithika Rajagopalan, Nazia Rashid, Dilesh Doshi
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of comparative effectiveness research 13 (1) (2023)
Krithika Rajagopalan, Nazia Rashid, Dilesh Doshi
Risk of long-term care admissions among Medicare beneficiaries treated with pimavanserin or quetiapine for Parkinson's disease psychosis in USA: a retrospective administrative claims database analysis. Journal of comparative effectiveness research 13 (1) (2023)
Roxanna Seyedin, Julia T Snider, Krithika Rajagopalan, Sally W Wade, Usama Gergis
Chimeric antigen receptor T-cell treatment patterns in relapsed or refractory large B-cell lymphoma. Future oncology (London, England) (2023)